AAAAAA

   
Results: 1-17 |
Results: 17

Authors: WALSH TJ HIEMENZ J
Citation: Tj. Walsh et J. Hiemenz, LIPID FORMULATIONS OF AMPHOTERICIN-B - RECENT DEVELOPMENTS IN IMPROVING THE THERAPEUTIC INDEX OF A GOLD STANDARD, Infectious diseases in clinical practice, 7, 1998, pp. 16-27

Authors: ANDRIOLE VT HIEMENZ J WALSH T
Citation: Vt. Andriole et al., LIPID FORMULATIONS OF AMPHOTERICIN-B - RECENT DEVELOPMENTS IN IMPROVING THE THERAPEUTIC INDEX OF A GOLD STANDARD - ROUND-TABLE DISCUSSION, Infectious diseases in clinical practice, 7, 1998, pp. 28-34

Authors: HIEMENZ J GORBACH S DISMUKES W KAUFFMAN C RUBIN R WINGARD J",ANDRIOLE
Citation: J. Hiemenz et al., EARLY INTERVENTION IN INVASIVE FUNGAL DISEASE WITH ANTIFUNGAL DRUGS -ROUND-TABLE DISCUSSION, Infectious diseases in clinical practice, 7, 1998, pp. 57-66

Authors: BALLESTER O SULLIVAN P HENDRIX L PERKINS J HIEMENZ J FIELDS K GOLDSTEIN S SULLIVAN D ELFENBEIN G
Citation: O. Ballester et al., INTERLEUKIN-3 IS EFFECTIVE FOR ENGRAFTMENT FAILURE FOLLOWING HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION, Experimental hematology, 24(9), 1996, pp. 431-431

Authors: TUMMALA R BALLESTER O JANSSEN W FIELDS K HIEMENZ J GOLDSTEIN S PERKINS J ROSEN R SAEZ R ELFENBEIN G
Citation: R. Tummala et al., HIGH-DOSE THERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA AND RENAL-FAILURE, Experimental hematology, 24(9), 1996, pp. 706-706

Authors: GOLDSTEIN S KRONISH L BALLESTER O HIEMENZ J SULLIVAN D SAEZ R SACKSTEIN R PARTYKA J PERKINS J JANSSEN W ELFENBEIN G FIELDS K
Citation: S. Goldstein et al., PHASE I II TRIAL OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) AT MAXIMUM TOLERATED DOSAGE (MTD) WITH AUTOLOGOUS STEM-CELL RESCUE FOR REFRACTORY LYMPHOMA/, Blood, 88(10), 1996, pp. 486-486

Authors: ZORSKY P FANG T JANSSEN W BALLESTER O FIELDS K GOLDSTEIN S HIEMENZ J ELFENBEIN G
Citation: P. Zorsky et al., THE WBC RECOVERY RATE AFTER PRIMING WITH CYVP16-BLOOD STEM-CELL RESCUE(GCSF IS A DETERMINANT OF ANC RECOVERY AND SURVIVAL AFTER BUCY2 AND AUTOLOGOUS PERIPHERAL), Blood, 86(10), 1995, pp. 391-391

Authors: BALLESTER O ZORSKY P JANSSEN W FIELDS K HIEMENZ J GOLDSTEIN S PERKINS J ROSEN R ELFENBEIN G
Citation: O. Ballester et al., HIGH-DOSE THERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA AND END-STAGE RENAL-FAILURE, Blood, 86(10), 1995, pp. 811-811

Authors: ZORSKY P BALLESTER O GOLDSTEIN S HIEMENZ J JANSSEN W FIELDS K ELFENBEIN G
Citation: P. Zorsky et al., COMPARISON OF CYCLOSPORINE (CSA) PLUS METHYLPREDNISOLONE (MEPRED) VS CSA PLUS METHOTREXATE (MTX) FOR GVHD PROPHYLAXIS IN HLA IDENTICAL ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 1573-1573

Authors: BENSON K LEPARC G VEGA R ZORSKY P FIELDS K HIEMENZ J BAZZINI M SANDIN R TOURAULT MA GREENE J
Citation: K. Benson et al., FATAL KLEBSIELLA-PNEUMONIAE SEPSIS DUE TO APHERESIS PLATELET CONTAMINATION, Blood, 86(10), 1995, pp. 3402-3402

Authors: FANG T ZORSKY T JANSSEN W HIEMENZ J BALLESTER O FIELDS K GOLDSTEIN S ELFENBEIN G
Citation: T. Fang et al., HEMATOLOGIC PARAMETERS OBTAINED BEFORE STEM-CELL PRIMING WITH CYVP-BLOOD STEM-CELL RESCUE (ASCR)(GCSF PREDICT OUTCOME AFTER BUCY2 PLUS AUTOLOGOUS PERIPHERAL), Blood, 86(10), 1995, pp. 3766-3766

Authors: WALSH TJ HIEMENZ J PIZZO PA
Citation: Tj. Walsh et al., EVOLVING RISK-FACTORS FOR INVASIVE FUNGAL-INFECTIONS - ALL NEUTROPENIC PATIENTS ARE NOT THE SAME, Clinical infectious diseases, 18(5), 1994, pp. 793-798

Authors: GOLDSTEIN S ALKAN S JANSSEN W THOMPSON J MOSCINSKI L BALLESTER O HIEMENZ J ZORSKY P PERKINS J FIELDS K ELFENBEIN G
Citation: S. Goldstein et al., CHEMOMOBILIZATION OF BCR ABL-NEGATIVE PERIPHERAL-BLOOD STEM-CELLS FORAUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOGENOUS LEUKEMIA/, Blood, 84(10), 1994, pp. 10000710-10000710

Authors: JANSSEN WE HIEMENZ J ZORSKY PE FIELDS KK BALLESTER O PERKINS J KRONISH L SMILEE R CARTER R RAHN D ELFENBEIN GJ
Citation: We. Janssen et al., MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - COMPARING CELL COLLECTIONS FROM CYCLOPHOSPHAMIDE AND GROWTH-FACTOR BASED REGIMENS, Experimental hematology, 21(8), 1993, pp. 1164-1164

Authors: BENSON K FIELDS K HIEMENZ J ZORSKY P BALLESTER O PERKINS J ELFENBEIN G
Citation: K. Benson et al., THE PLATELET-REFRACTORY BONE-MARROW TRANSPLANT PATIENT - PROPHYLAXIS AND TREATMENT OF BLEEDING, Seminars in oncology, 20(5), 1993, pp. 102-109

Authors: BALLESTER O JANSSEN W ELFENBEIN G FIELDS K HIEMENZ J ZORSKY P KRONISH L BEACH B FOODY M SHERMAN M
Citation: O. Ballester et al., RAPID ENGRAFTMENT FOLLOWING BUSULFAN CYCLOPHOSPHAMIDE AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION FOR HIGH-RISK HEMATOLOGICAL MALIGNANCIES, Blood, 82(10), 1993, pp. 10000626-10000626

Authors: AGALIOTIS D HIEMENZ J JANSSEN W FIELDS K ZORSKY P BALLESTER O ELFENBEIN G
Citation: D. Agaliotis et al., SUCCESSFUL HLA-MATCHED RELATED ALLOGENEIC BONE-MARROW (BM) ENGRAFTMENT WITH CADAVERIC DONOR CELLS, Blood, 82(10), 1993, pp. 10000626-10000626
Risultati: 1-17 |